New compounds have overcome a longstanding challenge by directly targeting β-arrestins, proteins that regulate cellular signals, providing laboratory tools that could help guide more precise treatments with fewer side effects. A drug can hit its intended target and still have its effects cut short. That’s because cells have built-in molecular brakes that dial down signals […]This is a curated summary.